Site Search

... patients. Beginning in the new year, Act 39 of 2024 will make it so that all patients who can benefit and are insured through a state-regulated health plan will receive coverage for biomarker testing, a game changer in the fight against cancer and an essential step in accessing precision medicine treatments. Pennsylvanians also secured a victory for access to care through Act 42 of 2024, the newly enacted legislation that includes telemedicine as a covered benefit in the Commonwealth. “This legislative ... so that a person’s economic status does not determine whether or not they have the ability to detect and survive cancer. “Soaring health care costs have made it so that patients are forced to take on medical debt and suffer through its cascading effects in order to receive ...

... the last few decades and is increasingly important in the treatment of other conditions, providing access to targeted treatment and tailoring care to a person’s individual disease. Targeted therapies often result in improved quality of life and survivorship. For example, patients with ... survivor and Philadelphia local Michael Hu. “When I was first diagnosed with metastatic lung cancer, I can recall my sister, who works in health care, saying to me, ‘the treatment you start on matters.’ Throughout the last two years, her words have stuck with me,” said Hu. ... advocacy affiliate, ACS CAN has successfully advocated for billions of dollars in cancer research funding, expanded access to quality affordable health care, and advanced proven tobacco control measures. We stand with our volunteers, working to make cancer a top priority for policymakers in ...

... Co-Director of the Precision Medicine Initiative at Sydney Kimmel Comprehensive Cancer Center at Jefferson, is a strong proponent of expanding health coverage of biomarker testing for more plans. In a recent visit to Harrisburg to advocate for lawmakers’ support of House Bill 1754, Dr. Johnson said, “Over the last two decades, oncologists’ vision of ‘high quality care’ has increasingly involved the use of precision medicine. Unfortunately, patients are not benefitting equitably from precision medicine, in ... Mullins, Minority Leader Cutler and Senators Robinson and Boscola in pursuing a policy that has drawn the support of providers, public health leaders and patients across the disease spectrum. We hope their colleagues in the Senate heed the call to expand the promise of precision ...

... on behalf of sexual assault survivors, she found herself working at the intersection of traumas, including cancer and a lack of access to health care. Greco brings with her a distinct expertise in policy development and grassroots organizing. ACS CAN is the nation’s leading cancer advocacy ... advocacy affiliate, ACS CAN has successfully advocated for billions of dollars in cancer research funding, expanded access to quality affordable health care, and advanced proven tobacco control measures. We’re more determined than ever to stand together with our volunteers to end cancer as ...